Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK

Biochemistry

Volumn 47, Issue 3, 2008, Pages 1094-1104

  Jung, Jin Hun ^a   Pendergast, Ann Marie ^b   Zipfel, Patricia A ^b,c   Traugh, Jolinda A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MECHANISMS; SERINES; SIGNALING MOLECULES;

ASSOCIATION REACTIONS; BINDING SITES; BIOMOLECULES; MOLECULAR MECHANICS; PHOSPHORYLATION;

ENZYME ACTIVITY;

ABELSON KINASE; ALANINE; ASPARTIC ACID; MUTANT PROTEIN; P21 ACTIVATED KINASE 2; PROTEIN ABI2; PROTEIN CRK; PROTEIN SH3; SERINE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE COMPLEX; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CDC42 GTP-BINDING PROTEIN; CELL LINE; GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; P21-ACTIVATED KINASES; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-CRK; RECOMBINANT PROTEINS; SERINE; TRANSFECTION;

EID: 38349094705     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701533j     Document Type: Article

References (66)

1. Goff, S. P., Gilboa, E., Witte, O. N., and Baltimore, D. (1980) Structure of the abelson murine leukemia virus genome and the homologous cellular gene studies with cloned viral DNA, Cell 22, 777-786.
2. Wang, J. Y. J., Ledley, F., Goff, S., Lee, R., Groner, Y., and Baltimore, D. (1984) The mouse c-abl locus molecular cloning and characterization, Cell 36, 349-356.
3. Van Etten, R. A. (1999) Cycling, stressed-out and nervous: Cellular functions of c-Abl, Trends Cell Biol. 9, 179-186.
4. Wang, J. Y. J. (1999) Integrative signaling through c-Abl: A tyrosine kinase with nuclear and cytoplasmic functions, in Cancer Drug Discovery and Development (Gutkind, J. S., Ed.) pp 303-324, Humana Press, Totowa, NJ.
5. Wang, J. Y. J. (2000) Regulation of cell death by the Abl tyrosine kinase, Oncogene 19, 5643-5650.
6. Pendergast, A. M. (2002) The Abl family kinases: Mechanisms of regulation and signaling, Adv. Cancer Res. 85, 51-100.
7. Van Etten, R. A., Jackson, P., and Baltimore, D. (1989) The mouse type iv c-abl gene product is a nuclear protein and activation of transforming ability is associated with cytoplasmic localization, Cell 58, 669-678.
8. Wang, J. Y. J. (1993) Abl tyrosine kinase in signal transduction and cell-cycle regulation, Curr. Opin. Genet. Dev. 3, 35-43.
9. Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y. J., and Hope, T. J. (1998) Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase, Proc. Natl. Acad. Sci. U.S.A. 95, 7457-7462.
10. Ito, Y., Pandey, P., Mishra, N., Kumar, S., Narula, N., Kharbanda, S., Saxena, S., and Kufe, D. (2001) Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis, Mol. Cell. Biol. 21, 6233-6242.
11. Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. (1995) Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents, Nature 376, 785-788.
12. Liu, Z.-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., and Wang, J. Y. J. (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress, Nature 384, 273-276.
13. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., and Pendergast, A. M. (1999) c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF, Genes Dev. 13, 2400-2411.
14. Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., and Kufe, D. (2000) Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species, J. Biol. Chem. 275, 17237-17240.
15. Dai, Z., and Pendergast, A. M. (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity, Genes Dev. 9, 2569-2582.
16. Shi, Y., Alin, K., and Goff, S. P. (1995) Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity, Genes Dev. 9, 2583-2597.
17. Biesova, Z., Piccoli, C., and Wong, W. T. (1997) Isolation and characterization of e3B1, and eps8 binding protein that regulates cell growth, Oncogene 14, 233-241.
18. Ikeguchi, A., Yang, H.-Y., Gao, G., and Goff, S. P. (2001) Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1, Oncogene 20, 4926-4934.
19. Dai, Z., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W., and Pendergast, A. M. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway, Genes Dev. 12, 1415-1424.
20. Birge, R. B., Fajardo, J. E., Mayer, B. J., and Hanafusa, H. (1992) Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze crk phosphotyrosine- dependent interactions in-vitro, J. Biol. Chem. 267, 10588-10595.
21. Knudsen, B. S., Feller, S. M., and Hanafusa, H. (1994) Four proline-rich sequences of the guanine-nucleotide exchange Factor C3G Bind with unique specificity to the first Src homology 3 domain of Crk, J. Biol. Chem. 269, 32781-32787.
22. Feller, S. M., Ren, R., Hanafusa, H., and Baltimore, D. (1994) SH2 and SH3 domains as molecular adhesives: The interactions of Crk and Abl, Trends Biochem. Sci. 19, 453-458.
23. Matsuda, M., Ota, S., Tanimura, R., Nakamura, H., Matuoka, K., Takenawa, T., Nagashima, K., and Kurata, T. (1996) Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins, J. Biol. Chem. 271, 14468-14472.
24. Beitner-Johnson, D., Blakesley, V. A., Shen-Orr, Z., Jimenez, M., Stannard, B., Wang, L.-M., Pierce, J., and Leroith, D. (1996) The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling, J. Biol. Chem. 271, 9287-9290.
25. Feller, S. M., Knudsen, B., and Hanafusa, H. (1994) C-Abl kinase regulates the protein binding activity of c-Crk, EMBO J. 13, 2341-2351.
26. Ren, R., Ye, Z.-S., and Baltimore, D. (1994) Abl protein: Tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites, Genes Dev. 8, 783-795.
27. Wang, B., Mysliwiec, T., Feller, S. M., Knudsen, B., Hanafusa, H., and Kruh, G. D. (1996) Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk, Oncogene 13, 1379-1385.
28. Shishido, T., Akagi, T., Chalmers, A., Maeda, M., Terada, T., Georgescu, M.-M., and Hanafusa, H. (2001) Crk family adaptor proteins trans-activate c-Abl kinase, Genes Cells 6, 431-440.
29. Brasher, B. B., and Van Etten, R. A. (2000) c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines, J. Biol. Chem. 275, 35631-35637.
30. Dorey, K., Engen, J. R., Kretzschmar, J., Wilm, M., Neubauer, G., Schindler, T., and Superti-Furga, G. (2001) Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase, Oncogene 20, 8075-8084.
31. Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., and Wang, J. Y. J. (1997) Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation, Nature 387, 516-519.
32. Roig, J., Tuazon, P. T., Zipfel, P. A., Pendergast, A. M., and Traugh, J. A. (2000) Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK, Proc. Natl. Acad. Sci. U.S.A. 97, 14346-14351.
33. Plattner, R., Irvin, B. J., Guo, S. L., Blackburn, K., Kazlauskas, A., Abraham, R. T., York, J. D., and Pendergast, A. M. (2003) A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma 1, Nat. Cell Biol. 5, 309-319.
34. Plattner, R., Koleske, A. J., Kazlauskas, A., and Pendergast, A. M. (2004) Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor, Mol. Cell. Biol. 24, 2573-2583.
35. Walter, B. N., Huang, Z., Jakobi, R., Tuazon, P. T., Alnemri, E. S., Litwack, G., and Traugh, J. A. (1998) Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (Caspase 3): Effects of autophosphorylation on activity, J. Biol. Chem. 273, 28733-28739.
36. Tuazon, P. T., Chinwah, M., and Traugh, J. A. (1998) Autophosphorylation and protein kinase activity of p21-activated protein kinase gamma-PAK are differentially affected by magnesium and manganese, Biochemistry 37, 17024-17029.
37. Gatti, A., Huang, Z., Tuazon, P. T., and Traugh, J. A. (1999) Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation, J. Biol. Chem. 274, 8022-8028.
38. Roig, J., Huang, Z., Lytle, C., and Traugh, J. A. (2000) p21-activated protein kinase gamma-PAK is translocated and activated in response to hyperosmolarity: Implication of Cdc42 and phosphoinositide 3-kinase in a two-step mechanism for gamma-PAK activation, J. Biol. Chem. 275, 16933-16940.
39. Roig, J., and Traugh, J. A. (1999) p21-activated protein kinase gamma-PAK is activated by ionizing radiation and other DNA-damaging agents: Similarities and differences to alpha-PAK, J. Biol. Chem. 274, 31119-31122.
40. Rooney, R. D., Tuazon, P. T., Meek, W. E., Carroll, E. J., Hagen, J. J., Gump, E. L., Monnig, C. A., Lugo, T., and Traugh, J. A. (1996) Cleavage arrest of early frog embryos by the G protein-activated protein kinase PAK I, J. Biol. Chem. 271, 21498-21504.
41. Huang, Z., Ling, J., and Traugh, J. A. (2003) Localization of p21-activated protein kinase gamma-PAK/Pak2 in the endoplasmic reticulum is required for induction of cytostasis, J. Biol. Chem. 278, 13101-13109.
42. Lee, N., MacDonald, H., Reinhard, C., Hallenbeck, R., Roulston, A., Shi, T., and Williams, L. T. (1997) Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis, Proc. Natl. Acad. Sci. U.S.A. 94, 13642-13647.
43. Jakobi, R., McCarthy, C. C., Koeppel, M. A., and Stringer, D. K. (2003) Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation, J. Biol. Chem. 278, 38675-38685.
44. Pendergast, A. M., Muller, A. J., Havlik, M. H., Clark, R., McCormick, F., and Witte, O. N. (1991) Evidence for regulation of the human abl tyrosine kinase by a cellular inhibitor, Proc. Natl. Acad. Sci. U.S.A. 88, 5927-5931.
45. Mayer, B. J., and Baltimore, D. (1994) Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase, Mol. Cell. Biol. 14, 2883-2894.
46. Jakobi, R., Huang, Z., Walter, B. N., Tuazon, P. T., and Traugh, J. A. (2000) Substrates enhance autophosphorylation and activation of p21-activated protein kinase gamma-PAK in the absence of activation loop phosphorylation, Eur. J. Biochem. 267, 4414-4421.
47. Jakobi, R., Chen, C.-J., Tuazon, P. T., and Traugh, J. A. (1996) Molecular cloning and sequencing of the cytostatic G protein-activated protein kinase PAK I, J. Biol. Chem. 271, 6206-6211.
48. Tuazon, P. T., Merrick, W. C., and Traugh, J. A. (1989) Comparative analysis of phosphorylation of translational initiation and elongation factors by seven protein kinases, J. Biol. Chem. 264, 2773-2777.
49. Sullivan, S., and Wong, T. W. (1991) A manual sequencing method for identification of phosphorylated amino acids in phosphopeptides, Anal. Biochem. 197, 65-68.
50. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., and Gishizky, M. L. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein, Cell 75, 175-185.
51. Orton, K. C., Ling, J., Waskiewicz, A. J., Cooper, J. A., Merrick, W. C., Korneeva, N. L., Rhoads, R. E., Sonenberg, N., and Traugh, J. A. (2004) Phosphorylation of Mnk1 by caspase-activated pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk, J. Biol. Chem. 279, 38649-38657.
52. Tuazon, P. T., Spanos, W. C., Gump, E. L., Monnig, C. A., and Traugh, J. A. (1997) Determinants for substrate phosphorylation by p21-activated protein kinase (gamma-PAK), Biochemistry 36, 16059-16064.
53. Smith, J. M., Katz, S., and Mayer, B. J. (1999) Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nek, J. Biol. Chem. 274, 27956-27962.
54. Amoui, M., and Miller, W. T. (2000) The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk, Cell. Signalling 12, 637-643.
55. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L. (1994) Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions, Science 266, 1241-1247.
56. Lim, W. A., Richards, F. M., and Fox, R. O. (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains, Nature 372, 375-379.
57. Zhou, G.-L., Zhuo, Y., King, C. C., Fryer, B. H., Bokoch, G. M., and Field, J. (2003) Akt phosphorylation of serine 21 on Pak1 modulates Nek binding and cell migration, Mol. Cell. Biol. 23, 8058-8069.
58. Zhao, Z.-S., Manser, E., and Lim, L. (2000) Interaction between PAK and Nek: A template for Nek targets and role of PAK autophosphorylation, Mol. Cell. Biol. 20, 3906-3917.
59. Ichigotani, Y., Fujii, K., Hamaguchi, M., and Matsuda, S. (2002) In search of a function for the E3B1/Abi2/Argbp1/NESH family, Int. J. Mol. Med. 9, 591-595.
60. Courtney, K. D., Grove, M., Vandongen, H., Vandongen, A., LaMantia, A.-S., and Pendergast, A. M. (2000) Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system, Mol. Cell. Neurosci. 16, 244-257.
61. Hu, H. L., Bliss, J. M., Wang, Y., and Colicelli, J. (2005) RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration, Curr. Biol. 15, 815-823.
62. Rosen, M. K., Yamazaki, T., Gish, G. D., Kay, C. M., Pawson, T., and Kay, L. E. (1995) Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein, Nature 374, 477-479.
63. Khwaja, A., Hallberg, B., Warne, P. H., and Downward, J. (1996) Networks of interaction of p120-cbl and p130-cas with Crk and Grb2 adaptor proteins, Oncogene 12, 2491-2498.
64. Okada, S., Matsuda, M., Anafi, M., Pawson, T., and Pessin, J. E. (1998) Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes, EMBO J. 17, 2554-2565.
65. Kain, K. H., and Klemke, R. L. (2001) Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes, J. Biol. Chem. 276, 16185-16192.
66. Kain, K. H., Gooch, S., and Klemke, R. L. (2003) Cytoplasmic c-Abl provides a molecular 'rheostat' controlling carcinoma cell survival and invasion, Oncogene 22, 6071-6080.